Brought to you by 
To fund Nucynta deal, Depomed gets $575mm loan from Deerfield, Pharmakon
18 Mar 2015
Executive Summary
Pain management company Depomed Inc. raised $575mm by selling senior secured notes to Deerfield affiliates (including Deerfield Private Design Fund III, Deerfield Partners, Deerfield International Master Fund, Deerfield Special Situations Fund, Deerfield Private Design Fund II, and Deerfield Private Design International II) and BioPharma Secured Investments III Holdings Cayman (managed by Pharmakon Advisors).
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
-
Drug Delivery
- Controlled Release
Deal Status
- Final
Deal Type
-
Financing
- Nonconvertible Debt
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
To fund Nucynta deal, Depomed gets $575mm loan from Deerfield, Pharmakon
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice